KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Fulgent Genetics (FLGT) over the last 9 years, with Q3 2025 value amounting to $7.6 million.

  • Fulgent Genetics' Other Non-Current Liabilities fell 3603.89% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year decrease of 3603.89%. This contributed to the annual value of $7.0 million for FY2024, which is 5377.22% down from last year.
  • As of Q3 2025, Fulgent Genetics' Other Non-Current Liabilities stood at $7.6 million, which was down 3603.89% from $5.9 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Other Non-Current Liabilities ranged from a high of $21.7 million in Q2 2022 and a low of $513000.0 during Q1 2021
  • For the 5-year period, Fulgent Genetics' Other Non-Current Liabilities averaged around $11.3 million, with its median value being $11.8 million (2024).
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first surged by 179200.78% in 2022, then crashed by 5898.45% in 2025.
  • Over the past 5 years, Fulgent Genetics' Other Non-Current Liabilities (Quarter) stood at $6.8 million in 2021, then skyrocketed by 167.96% to $18.2 million in 2022, then fell by 17.28% to $15.1 million in 2023, then plummeted by 53.77% to $7.0 million in 2024, then rose by 8.38% to $7.6 million in 2025.
  • Its last three reported values are $7.6 million in Q3 2025, $5.9 million for Q2 2025, and $6.1 million during Q1 2025.